EP2 and EP4 prostanoid receptor signaling

被引:363
|
作者
Regan, JW [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
关键词
G-protein coupled receptors; prostaglandins; PGE2; cAMP; cancer;
D O I
10.1016/j.lfs.2003.09.031
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The EP2 and EP4 prostanoid receptors are two of the four subtypes of receptors for prostaglandin E-2 (PGE(2)). They are in the family of G-protein coupled receptors and both receptors were initially characterized as coupling to Gs and increasing intracellular cAMP formation. Recently, however, we have shown that both receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity. The EP2 receptor does this primarily through cAMP-dependent protein kinase (PKA), whereas the EP4 utilizes phosphatidylinositol 3-kinase (PI3K) as well as PKA. In addition, we have shown that the EP4 receptor, but not the EP2, can activate the extracellular signal-regulated kinases (ERKs) I and 2 by way of PI3K leading to the induction of early growth response factor-1 (EGR-1), a transcription factor traditionally associated with wound healing. This induction of EGR-1 expression has significant implications concerning the potential role of PGE(2) in cancer and inflammatory disorders. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [1] Functional pharmacology of human prostanoid EP2 and EP4 receptors
    Wilson, RJ
    Rhodes, SA
    Wood, RL
    Shield, VJ
    Noel, LS
    Gray, DW
    Giles, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) : 49 - 58
  • [2] Fluid flow shear stress upregulates prostanoid receptor EP2 but not EP4 in murine podocytes
    Srivastava, Tarak
    McCarthy, Ellen T.
    Sharma, Ram
    Kats, Alexander
    Carlton, Carol G.
    Alon, Uri S.
    Cudmore, Patricia A.
    El-Meanawy, Ashraf
    Sharma, Mukut
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 104 : 49 - 57
  • [3] EP4 PROSTANOID RECEPTOR SIGNALING IN HUMAN EOSINOPHILS
    Sturm, Eva
    Parzmair, Gerald-Peter
    Luschnig-Schratl, Petra
    Konya, Viktoria
    Heinemann, Akos
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 421 - 422
  • [4] The Prostanoid EP4 Receptor and Its Signaling Pathway
    Yokoyama, Utako
    Iwatsubo, Kousaku
    Umemura, Masanari
    Fujita, Takayuki
    Ishikawa, Yoshihiro
    PHARMACOLOGICAL REVIEWS, 2013, 65 (03) : 1010 - 1052
  • [5] EP4 and EP2 receptor subtypes involved in colonic secretion in rat
    Mosa, Ahmed Soliman
    Hansen, Mark Berner
    Tilotta, Cristina Maria
    Bindslev, Niels
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (03) : 214 - 221
  • [6] Ocular inflammatory responses in the EP2 and EP4 receptor knockout mice
    Biswas, S.
    Bhattacherjee, P.
    Paterson, C. A.
    Tilley, S. L.
    Koller, B. H.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2006, 14 (03) : 157 - 163
  • [7] Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle
    Huang, Na
    Liu, Bo
    Dong, Zhiheng
    Mao, Wei
    Zhang, Nan
    Li, Changyou
    Cao, Jinshan
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2015, 121 : 170 - 175
  • [8] Synthesis and evaluation of γ-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists
    Kambe, Tohru
    Maruyama, Toru
    Nakai, Yoshihiko
    Oida, Hiroji
    Maruyama, Takayuki
    Abe, Nobutaka
    Nishiura, Akio
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (11) : 3502 - 3522
  • [9] Comparison of the Effects of an EP2, EP4 and EP2/4 Agonist on Aqueous Humor Dynamics in Monkeys
    Toris, C. B.
    Fan, S.
    Stapp, L. S.
    Rudebush, T. L.
    Prasanna, G.
    Anderson, S.
    Krauss, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] Prostanoid Receptor EP2 as a Therapeutic Target
    Ganesh, Thota
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4454 - 4465